Published in RNA on October 30, 2008
A long-range RNA-RNA interaction between the 5' and 3' ends of the HCV genome. RNA (2009) 1.34
Optimal packaging of FIV genomic RNA depends upon a conserved long-range interaction and a palindromic sequence within gag. J Mol Biol (2010) 0.94
SHAPE analysis of the FIV Leader RNA reveals a structural switch potentially controlling viral packaging and genome dimerization. Nucleic Acids Res (2011) 0.93
SHAPE analysis of the 5' end of the Mason-Pfizer monkey virus (MPMV) genomic RNA reveals structural elements required for genome dimerization. RNA (2013) 0.81
Sequences within both the 5' UTR and Gag are required for optimal in vivo packaging and propagation of mouse mammary tumor virus (MMTV) genomic RNA. PLoS One (2012) 0.80
Structural basis of genomic RNA (gRNA) dimerization and packaging determinants of mouse mammary tumor virus (MMTV). Retrovirology (2014) 0.80
Current perspectives on RNA secondary structure probing. Biochem Soc Trans (2014) 0.80
Probing Retroviral and Retrotransposon Genome Structures: The "SHAPE" of Things to Come. Mol Biol Int (2012) 0.80
Packaging of Mason-Pfizer monkey virus (MPMV) genomic RNA depends upon conserved long-range interactions (LRIs) between U5 and gag sequences. RNA (2016) 0.76
Single aromatic residue location alters nucleic acid binding and chaperone function of FIV nucleocapsid protein. Virus Res (2014) 0.76
Orchestrating the Selection and Packaging of Genomic RNA by Retroviruses: An Ensemble of Viral and Host Factors. Viruses (2016) 0.76
Cross- and Co-Packaging of Retroviral RNAs and Their Consequences. Viruses (2016) 0.75
Two ribosome recruitment sites direct multiple translation events within HIV1 Gag open reading frame. Nucleic Acids Res (2017) 0.75
Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89
Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol (1999) 41.48
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (1987) 6.56
Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J Virol (1989) 6.11
An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization. Cell (1978) 4.66
Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc Natl Acad Sci U S A (1989) 4.57
Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J Mol Biol (1990) 4.38
Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res (1988) 3.89
The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J (1997) 3.10
Modified nucleotides of tRNA(3Lys) modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription. J Biol Chem (1993) 2.95
On the recognition of helical RNA by cobra venom V1 nuclease. J Biol Chem (1986) 2.66
Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro. J Biol Chem (1993) 2.26
Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. Proc Natl Acad Sci U S A (1989) 2.21
A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon. J Biol Chem (2002) 1.81
Retroviral RNA packaging: a review. Arch Virol Suppl (1994) 1.80
In vitro evidence for a long range pseudoknot in the 5'-untranslated and matrix coding regions of HIV-1 genomic RNA. J Biol Chem (2001) 1.62
Occlusion of the HIV poly(A) site. Genes Dev (1991) 1.53
Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus among Felidae and Hyaenidae species. J Virol (2005) 1.47
Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5' and 3' of the catalytic site. Nucleic Acids Res (1998) 1.43
The retroviral RNA dimer linkage: different structures may reflect different roles. Retrovirology (2004) 1.40
HIV-1 RNA packaging. Adv Pharmacol (2007) 1.38
Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2. J Virol (1997) 1.34
The effect of template RNA structure on elongation by HIV-1 reverse transcriptase. Biochim Biophys Acta (1999) 1.22
Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function. AIDS Res Hum Retroviruses (1990) 1.19
Identification of a high affinity nucleocapsid protein binding element within the Moloney murine leukemia virus Psi-RNA packaging signal: implications for genome recognition. J Mol Biol (2001) 1.19
Mapping the encapsidation determinants of feline immunodeficiency virus. J Virol (2002) 1.18
Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J Virol (2001) 1.08
Role of the 5' TAR stem--loop and the U5-AUG duplex in dimerization of HIV-1 genomic RNA. Biochemistry (2008) 1.03
Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation. J Virol (2006) 1.02
Molecular mechanisms of FIV infection. Vet Immunol Immunopathol (2008) 1.02
Genomic organization, sequence divergence, and recombination of feline immunodeficiency virus from lions in the wild. BMC Genomics (2008) 0.96
FIV: from lentivirus to lentivector. J Gene Med (2004) 0.96
Delineation of sequences important for efficient packaging of feline immunodeficiency virus RNA. J Gen Virol (2003) 0.93
Sequences within the gag gene of feline immunodeficiency virus (FIV) are important for efficient RNA encapsidation. Virus Res (2003) 0.93
Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA. J Mol Biol (2002) 0.93
The critical role of proximal gag sequences in feline immunodeficiency virus genome encapsidation. Virology (2004) 0.92
RNA secondary structure of the feline immunodeficiency virus 5'UTR and Gag coding region. Nucleic Acids Res (2008) 0.90
Recombination in feline immunodeficiency virus genomes from naturally infected cougars. Virology (2007) 0.85
A dormant internal ribosome entry site controls translation of feline immunodeficiency virus. J Virol (2008) 0.84
Both the 5' and 3' LTRs of FIV contain minor RNA encapsidation determinants compared to the two core packaging determinants within the 5' untranslated region and gag. Microbes Infect (2006) 0.82
HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET. Traffic (2005) 1.46
Emergence and spread of NDM-1 producer Enterobacteriaceae with contribution of IncX3 plasmids in the United Arab Emirates. J Med Microbiol (2013) 1.27
HIV Gag polyprotein: processing and early viral particle assembly. Trends Microbiol (2012) 1.26
Selective recognition of acetylated histones by bromodomains in transcriptional co-activators. Biochem J (2007) 1.08
Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation. J Virol (2006) 1.02
Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic Res Cardiol (2002) 1.00
Rev regulates translation of human immunodeficiency virus type 1 RNAs. J Gen Virol (2009) 0.97
In-gel probing of individual RNA conformers within a mixed population reveals a dimerization structural switch in the HIV-1 leader. Nucleic Acids Res (2013) 0.96
Rev binds specifically to a purine loop in the SL1 region of the HIV-1 leader RNA. J Biol Chem (2003) 0.95
Plasmid-encoded PER-7 β-lactamase responsible for ceftazidime resistance in Acinetobacter baumannii isolated in the United Arab Emirates. J Antimicrob Chemother (2012) 0.94
Optimal packaging of FIV genomic RNA depends upon a conserved long-range interaction and a palindromic sequence within gag. J Mol Biol (2010) 0.94
Delineation of sequences important for efficient packaging of feline immunodeficiency virus RNA. J Gen Virol (2003) 0.93
SHAPE analysis of the FIV Leader RNA reveals a structural switch potentially controlling viral packaging and genome dimerization. Nucleic Acids Res (2011) 0.93
Sequences within the gag gene of feline immunodeficiency virus (FIV) are important for efficient RNA encapsidation. Virus Res (2003) 0.93
Characteristics of epidemic and sporadic strains of Acinetobacter baumannii isolated in Abu Dhabi hospitals. J Med Microbiol (2012) 0.93
Dimerisation of HIV-2 genomic RNA is linked to efficient RNA packaging, normal particle maturation and viral infectivity. Retrovirology (2007) 0.92
Three-dimensional RNA structure of the major HIV-1 packaging signal region. Structure (2013) 0.91
2008 Nobel prize in medicine for discoverers of HIV. Retrovirology (2008) 0.91
Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells. Cancer Biother Radiopharm (2011) 0.90
Relative activity of the feline immunodeficiency virus promoter in feline and primate cell lines. Microbes Infect (2005) 0.90
Case report: Severe typhus group rickettsiosis complicated by pulmonary edema in a returning traveler from Indonesia. Am J Trop Med Hyg (2011) 0.89
XMRV, prostate cancer and chronic fatigue syndrome. Br Med Bull (2011) 0.88
Role of a heterologous retroviral transport element in the development of genetic complementation assay for mouse mammary tumor virus (MMTV) replication. Virology (2009) 0.86
High incidence of New Delhi metallo-beta-lactamase-producing Klebsiella pneumoniae isolates in Sharjah, United Arab Emirates. Microb Drug Resist (2013) 0.86
Lentiviral vectors for gene delivery to normal and demyelinated white matter. Glia (2003) 0.86
(-)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells. Asian Pac J Cancer Prev (2012) 0.86
Mutation of the Rev-binding loop in the human immunodeficiency virus 1 leader causes a replication defect characterized by altered RNA trafficking and packaging. J Gen Virol (2006) 0.86
Antiviral activity of steric-block oligonucleotides targeting the HIV-1 trans-activation response and packaging signal stem-loop RNAs. Nucleosides Nucleotides Nucleic Acids (2005) 0.85
Comparative structural effects of HIV-1 Gag and nucleocapsid proteins in binding to and unwinding of the viral RNA packaging signal. Biochemistry (2012) 0.84
Sequences within both the 5' untranslated region and the gag gene are important for efficient encapsidation of Mason-Pfizer monkey virus RNA. Virology (2003) 0.84
Hepatocyte-specific gene expression from integrated lentiviral vectors. J Gene Med (2004) 0.84
A G-C-rich palindromic structural motif and a stretch of single-stranded purines are required for optimal packaging of Mason-Pfizer monkey virus (MPMV) genomic RNA. J Mol Biol (2010) 0.84
Change in meticillin-resistant Staphylococcus aureus clones at a tertiary care hospital in the United Arab Emirates over a 5-year period. J Clin Pathol (2011) 0.84
The molecular biology of feline immunodeficiency virus (FIV). Viruses (2011) 0.83
Intracellular defenses against HIV, viral evasion and novel therapeutic approaches. J Formos Med Assoc (2011) 0.82
Cross-packaging of genetically distinct mouse and primate retroviral RNAs. Retrovirology (2009) 0.82
Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction. Retrovirology (2005) 0.82
Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 expression. Cancer Epidemiol (2012) 0.82
Both the 5' and 3' LTRs of FIV contain minor RNA encapsidation determinants compared to the two core packaging determinants within the 5' untranslated region and gag. Microbes Infect (2006) 0.82
SHAPE analysis of the 5' end of the Mason-Pfizer monkey virus (MPMV) genomic RNA reveals structural elements required for genome dimerization. RNA (2013) 0.81
Tri-partite complex for axonal transport drug delivery achieves pharmacological effect. BMC Neurosci (2010) 0.80
Reciprocal cross-packaging of primate lentiviral (HIV-1 and SIV) RNAs by heterologous non-lentiviral MPMV proteins. Virus Res (2010) 0.80
Targeting RNA-protein interactions within the human immunodeficiency virus type 1 lifecycle. Biochemistry (2013) 0.80
Sequences within both the 5' UTR and Gag are required for optimal in vivo packaging and propagation of mouse mammary tumor virus (MMTV) genomic RNA. PLoS One (2012) 0.80
Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2. J Virol (2004) 0.79
Lentivirus-mediated gene expression. Methods Mol Biol (2007) 0.79
Identification and visualization of the dimerization initiation site of the prototype lentivirus, maedi visna virus: a potential GACG tetraloop displays structural homology with the alpha- and gamma-retroviruses. Biochemistry (2005) 0.78
The human T-cell lymphotropic virus type-I dimerization initiation site forms a hairpin loop, unlike previously characterized retroviral dimerization motifs. Biochemistry (2004) 0.78
Inhibition of HIV-1 replication by oligonucleotide analogues directed to the packaging signal and trans-activating response region. Antivir Chem Chemother (2006) 0.78
A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax. J Infect (2012) 0.78
Functional characterization of late outgrowth endothelial progenitor cells in patients with end-stage renal failure. Transpl Int (2014) 0.78
Mutational analysis of the predicted secondary RNA structure of the Mason-Pfizer monkey virus packaging signal. Virus Res (2004) 0.78
The rapidly emerging ESBL-producing Escherichia coli O25-ST131 clone carries LPS core synthesis genes of the K-12 type. FEMS Microbiol Lett (2012) 0.78
Lipidome analysis of rotavirus-infected cells confirms the close interaction of lipid droplets with viroplasms. J Gen Virol (2013) 0.77
Anti-HIV activity of steric block oligonucleotides. Ann N Y Acad Sci (2006) 0.77
An update on malaria prevention, diagnosis and treatment for the returning traveller. Blood Rev (2006) 0.77
Poor survival but high immunogenicity of IL-2-expressing Salmonella typhimurium in inherently resistant mice. Microbes Infect (2004) 0.76
Endovascular aortic stent graft infection with Streptococcus equi: the first documented case. Vascular (2011) 0.76
Rapamycin-induced inhibition of HTLV-I LTR activity is rescued by c-Myb. Retrovirology (2007) 0.76
Reversible parkinsonism in a patient with progressive multifocal leucoencephalopathy. J Neurol Neurosurg Psychiatry (2007) 0.75
Bioenergetics of murine lungs infected with respiratory syncytial virus. Virol J (2013) 0.75
Close proximity of the MPMV CTE to the polyadenylation sequences is important for efficient function in the subgenomic context. Virus Res (2004) 0.75
A case of Mycoplasma hominis septic arthritis postpartum. J Infect (2007) 0.75
A husband and wife with left hand rashes. Lancet Infect Dis (2005) 0.75
Estrogenic activities of ten medicinal herbs from the Middle East. J Chromatogr Sci (2012) 0.75
Risk of blood-borne infections in barber shops. J Infect Public Health (2010) 0.75
Steric block high affinity oligonucleotide analogues: a new tool for mapping RNA-protein binding sites. Nucleosides Nucleotides Nucleic Acids (2008) 0.75